- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Phivida Featured in Baystreet Article on Latest Warrant Conversion
Phivida Holdings Inc (CSE:VIDA) was featured on Baystreet in an article about the company’s warrant conversion.
Phivida Holdings Inc (CSE:VIDA) was featured on Baystreet in an article about the company’s warrant conversion.
The article positioned Phivida as a powerful new entrant to the medical cannabis sector which is capturing the imagination of investors. The author writes “few companies have sprinted from the starting gun harder and faster than Vancouver-based Phivida, offering cannabidiol (“CBD”) infused functional foods, beverages and clinical products.“
The article outlined the warrant conversion and how it’s a good news for shareholders. The author stresses that through the warrant conversion they have an opportunity to maintain their pro-rata position at a lower risk level, by converting and holding.
The article further discussed about the effects of the conversion and states that “the effect of this conversion is a company with about $11 million in cash—effectively doubling Phivida’s position in only 24 trading days.”
The article further talks about the company’s future and ongoing practices in favourable words. “Phivida is rapidly developing CBD infused products under three banners: 1. Organics: professional grade, wholesale whole plant hemp oil extracts; 2. Nutrition: iced tea, vitamin juice and shakes; and 3. Enhanced: tinctures and vitamin shots. In the US, Phivida has already secured a distribution agreement in California and a brand licensing agreement in Oregon with an eye on more agreement to come from Washington and Colorado. Internationally, Phivida recently named Namaste as its preferred global online retailer, initially focused on the German and Australian territories. The company also secured a product distribution agreement with Asayake Inc. to sell its cannabidiol products across Japan. At this pace, and with plenty of fuel in the tank, investors can look forward to more agreements from Phivida in the weeks, months, and years to come,” concluded the author.
Click here to read the complete article
Click here to connect with Phivida Holdings Inc (CSE:VIDA) to receive an Investor Presentation.
Source: www.baystreet.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.